Tamoxifen Citrate
- Product NDC
- 0378-0274
- 11-digit product format
- 003780274
- Labeler code
- 0378
- Product ID
- 0378-0274_2c1fe025-1eb2-4b2f-b8c9-5d0cfc3c683e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tamoxifen Citrate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Mylan Pharmaceuticals Inc.
- Application
- ANDA074732
- Marketing category
- ANDA
- Marketing start
- 2003-02-20
- Substance
- TAMOXIFEN CITRATE
- Active strength
- 20 mg/1
- Pharmacologic classes
- Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Tamoxifen Citrate
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TAMOXIFEN CITRATE | 20 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 7FRV7310N6 |
| Rxcui | 198240, 313195 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0378-0274-93 | Tamoxifen Citrate | 30 in 1 BOTTLE | TABLET | 30 | | 13 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0378-0274 | TAMOXIFEN CITRATE TABLET [MYLAN PHARMACEUTICALS INC.] | 11 | Current NDC, Legacy NDC, 1 package rows | 20230823_7ee3d3d2-85d1-4018-8e70-5ed8a64ae1f0.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0378-0274-93 | 00378027493 | 30 TABLET in 1 BOTTLE (0378-0274-93) | 30 tablet | 2003-02-20 | 0000-00-00 | No | No | Current |